A Study to Investigate the Effects of JNJ-38518168 on Methotrexate Pharmacokinetics in Rheumatoid Arthritis Participants on a Stable Methotrexate Dose.

Trial Profile

A Study to Investigate the Effects of JNJ-38518168 on Methotrexate Pharmacokinetics in Rheumatoid Arthritis Participants on a Stable Methotrexate Dose.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 May 2013

At a glance

  • Drugs Methotrexate; Toreforant
  • Indications Rheumatic disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Dec 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 23 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Dec 2011 Actual patients number (20) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top